Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

Clinical trial NCT04406623 · COMPLETED

Trial details

NCT number: NCT04406623
Sponsor: Shattuck Labs, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2020-06-29
Primary completion: 2023-02-02
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.